© accelopment Schweiz AG · [email protected] · ISO 9001 certified · Read our Privacy Policy
The deliverable D1.1 is part of Work Package (WP) 1 – Project management and collaboration with other initiatives and reports on virtual meeting with the other successful projects working on COVID-19 therapeutics funded under the Horizon Europe Health Emergency preparedness and Response Authority (HERA) incubator call “HORIZON-HLTH-2021-CORONA-01” summarises the main presentations and outcomes of the meeting held online on the 6th of April.
The deliverable D1.8 is part of Work Package (WP) 1 – Project management and collaboration with other initiatives and reports about the first activities with other research and innovation initiatives and all the established contacts.
The deliverable 7.1 is part of Work Package (WP) 7 – Socio-economic impact and cost effectiveness analyses (HTA) and explores relevant policies in the process of reimbursement and payment of new interventions to be used in a hospital setting and identifies differences and similarities across national methodological guidelines for the conduct of HEEs.
After the comparative overview provided in D7.1, the current deliverable 7.2 identifies factors that could positively (as facilitators) or negatively (as barriers) affect the implementation of FX06 in the treatment of hospitalised patients suffering from mild to moderate symptoms of COVID-19, and how these may differ between participating countries.
The deliverable is part of Work Package (WP) 8 – Communication, dissemination and exploitation and presents the COVend project website, describing the main structure of the website, how it is set up and how it will be maintained throughout the project’s duration and for the five years following its completion.
The deliverable is part of Work Package (WP) 8 – Communication, dissemination and its main goal is to describe which training material will be developed for local site initiation as part of the COVend study to inform and train the clinical staff involved on the COVend study, how to provide verification of the study data and ensure patients’ safety.
The deliverable is part of Work Package (WP) 8 – Communication, dissemination and presents the COVend plan for dissemination, including communication activities and describes the main strategy of the COVend consortium to maximise its project impact.
The document represents Deliverable 8.5 – Interim impact report – and has been developed as part of WP8 – Communication, dissemination & exploitation. The main goal of this deliverable is to present an evaluation of the communication and dissemination activities implemented during the first 24 months of the project and their impact towards reaching scientific, economic and societal goals.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
FOR INQUIRIES, PLEASE SEND US AN EMAIL AT [email protected]
© accelopment Schweiz AG · [email protected] · ISO 9001 certified · Read our Privacy Policy